Table 4

Changes in median expression and corresponding null probability values () for pair-wise comparison of disease classes and the non-fatigued control group for each individual gene in the CD19+ B cell Up-regulated gene set

3-Class (NF Controls)

7-Class (Controls = LCA-0 U LCA-2)

Gene

ISF

CFS

LCA-1

LCA-3

LCA-4

LCA-5

LCA-6

SP140

-0.03 (0.60)

0.02 (0.49)

-0.07 (0.43)

0.10 (0.60)

0.01 (0.72)

-0.08 (0.29)

0.07 (0.92)

CD22

-0.16 (0.10)

-0.09 (0.31)

-0.14 (0.17)

-0.58 (0.02)

-0.30 (0.04)

0.02 (0.35)

0.05 (0.70)

QRSL1

-0.03 (0.95)

-0.21 (0.91)

0.29 (0.28)

-0.10 (0.70)

0.23 (0.50)

-0.16 (0.89)

-0.49 (0.42)

PTPRK

-0.12 (0.55)

-0.21 (0.18)

-0.12 (0.76)

-0.07 (0.82)

-0.22 (0.68)

-0.20 (0.17)

-0.07 (0.64)

P2RY10

0.01 (0.21)

-0.02 (0.51)

0.08 (0.99)

-0.08 (0.06)

0.28 (0.82)

0.11 (0.94)

0.20 (0.33)

TSPAN3

-0.10 (0.54)

-0.20 (0.19)

-0.24 (0.39)

-0.17 (0.83)

0.13 (0.38)

-0.08 (0.83)

-0.02 (0.82)

Aspler et al. Behavioral and Brain Functions 2008 4:44   doi:10.1186/1744-9081-4-44